We are live on
!
Find out more
DFO
Duquesne Family Office Portfolio holdings
AUM
$3.38B
1-Year Est. Return
61.92%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$787M
AUM Growth
-$233M
(-23%)
Cap. Flow
-$292M
Cap. Flow
% of AUM
-37.08%
Top 10 Holdings %
Top 10 Hldgs %
65.21%
Holding
49
New
14
Increased
3
Reduced
6
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$60.3M |
| 2 |
EOG Resources
EOG
|
+$50.7M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$46M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$34.5M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$72.7M |
| 2 |
Target
TGT
|
+$57.7M |
| 3 |
Home Depot
HD
|
+$55.5M |
| 4 |
Lowe's Companies
LOW
|
+$46M |
| 5 |
Costco
COST
|
+$40.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.82% |
| 2 | Energy | 20.05% |
| 3 | Technology | 15.89% |
| 4 | Financials | 8.31% |
| 5 | Materials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Illumina
ILMN
$31B
| $76.1M | 9.67% |
421,583
| – | – |
|
|
2
Biogen
BIIB
$30.7B
| $73.9M | 9.39% |
175,000
-184,400
| -51% | -$72.7M |
|
|
3
LyondellBasell Industries
LYB
$19.5B
| $62.9M | 8% |
+716,950
| New | +$60.3M |
|
4
HDFC Bank
HDB
$124B
| $59.1M | 7.51% |
4,014,400
| – | – |
|
|
5
EOG Resources
EOG
$77.5B
| $51.5M | 6.54% |
+561,600
| New | +$50.7M |
|
|
6
Teva Pharmaceuticals
TEVA
$41.2B
| $49.2M | 6.26% |
+790,500
| New | +$46M |
|
7
Cognizant
CTSH
$24.3B
| $45.4M | 5.76% |
726,900
+357,300
| +97% | +$21.1M |
|
|
PXD
8
DELISTED
Pioneer Natural Resource Co.
PXD
| $36.7M | 4.66% |
+224,500
| New | +$34.5M |
|
|
NBL
9
DELISTED
Noble Energy, Inc.
NBL
| $30.4M | 3.86% |
+621,300
| New | +$29M |
|
10
Workday
WDAY
$39B
| $27.9M | 3.55% |
330,679
| – | – |
|
11
Infosys
INFY
$48.4B
| $26.5M | 3.37% |
3,026,000
+531,200
| +21% | +$4.68M |
|
12
Akamai
AKAM
$16.5B
| $25.2M | 3.21% |
+355,300
| New | +$23.5M |
|
|
CELG
13
DELISTED
Celgene Corp
CELG
| $22.6M | 2.87% |
195,975
-238,125
| -55% | -$28.5M |
|
|
BLUE
14
DELISTED
bluebird bio
BLUE
| $22.2M | 2.83% |
14,211
-13,226
| -48% | -$17.5M |
|
15
Meta Platforms (Facebook)
META
$1.37T
| $20.7M | 2.63% |
252,000
-178,000
| -41% | -$13.9M |
|
16
Cheniere Energy
LNG
$54.1B
| $20M | 2.54% |
+258,700
| New | +$19.3M |
|
17
Alibaba
BABA
$279B
| $19.9M | 2.53% |
239,500
-14,400
| -6% | -$1.3M |
|
18
Restaurant Brands International
QSR
$25.8B
| $19.7M | 2.51% |
+514,000
| New | +$20.5M |
|
19
YPF
YPF
$20.4B
| $19.2M | 2.44% |
698,300
+399,400
| +134% | +$10.3M |
|
20
Baidu
BIDU
$36.5B
| $18M | 2.28% |
+86,200
| New | +$18.5M |
|
21
Expedia Group
EXPE
$35.2B
| $15.1M | 1.91% |
+160,000
| New | +$14.2M |
|
22
MacroGenics
MGNX
$240M
| $14.8M | 1.88% |
472,500
| – | – |
|
23
Nektar Therapeutics
NKTR
$2.41B
| $7.21M | 0.92% |
43,667
| – | – |
|
24
Banco Macro
BMA
$6.02B
| $6.3M | 0.8% |
+110,100
| New | +$5.46M |
|
|
MFRM
25
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
| $6.05M | 0.77% |
86,900
-89,300
| -51% | -$5.5M |
|
Similar funds
VFCM
OAM
EFM
BG
DIA
5NCM
TAM
BCM
Duquesne Family Office's Q1 2015 Portfolio in Review
As of Q1 2015, Duquesne Family Office held 49 positions worth $787M, down 23% from $1.02B the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Duquesne Family Office withdrew a net $292M in Q1 2015, closing 21 positions and reducing 6 holdings. Its most notable exit was Target, an estimated $57.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 30% a quarter earlier, followed by Energy and Technology.
Against the trend, Duquesne Family Office opened a new position in LyondellBasell Industries worth $62.9M.
- Duquesne Family Office's largest Q1 2015 buy was LyondellBasell Industries: 716,950 shares worth $62.9M.
- Duquesne Family Office added most to Cognizant in Q1 2015, an estimated $21.1M increase.
- Duquesne Family Office's biggest Q1 2015 reduction was Biogen, cutting an estimated $72.7M.
- Duquesne Family Office fully exited Target in Q1 2015, selling an estimated $57.7M.
- Duquesne Family Office's ten largest holdings make up 65% of its $787M portfolio in Q1 2015.
- Duquesne Family Office opened 14 new positions and closed 21 in Q1 2015.
- Duquesne Family Office's portfolio value fell 23% quarter-over-quarter to $787M.
Based on Duquesne Family Office's 13F filing for Q1 2015, filed 15 May 2015.